Web Results
Content Results
  • Manchuria

    serch.it?q=Manchuria

    Manchuria () is a name first used in the 17th century by Japanese people to refer to a large geographic region in Northeast Asia. Depending on the context, Manchuria can either refer to a region that falls entirely within the People's Republic of China or a larger region divided between China and Russia. "Manchuria" is widely used outside China to denote the geographical and historical region. This region is the traditional homeland of the Xianbei, Khitan, and Jurchen (later called Manchu 满族) peoples, who built several states within the area historically (however, no term for "Manchuria" exists in the Manchu language, which originally referred to the area as the "Three Eastern Provinces"; mnc. , Dergi ilan golo; zh. 東三省 / 东三省, Dōng Sānshěng).

  • Gennady Golovkin

    serch.it?q=Gennady-Golovkin

    Gennady Gennadyevich Golovkin (Cyrillic: ; born 8 April 1982), often known by his nickname "GGG" or "Triple G", is a Kazakhstani professional boxer. He is a former unified middleweight world champion, having held the WBA (Super), WBC, IBF, and IBO titles between 2010 and 2018. As of October 2018, he is ranked as the world's second best active middleweight by The Ring magazine, the Transnational Boxing Rankings Board (TBRB), and BoxRec. He is also ranked as the world's fifth best active boxer, pound for pound, by The Ring; third by BoxRec; and eighth by the TBRB. Golovkin won his first major world championship, the WBA interim middleweight title, by defeating Milton Núñez in 2010. The WBA elevated him to Regular champion status in the same year, and in 2011 he won the vacant IBO middleweight title by defeating Lajuan Simon. In 2014, Golovkin was elevated to his current status of WBA (Super) champion and successfully defended both his titles against Daniel Geale. Later that year he defeated Marco Antonio Rubio to win WBC interim middleweight title, and defeated David Lemieux for the IBF middleweight title in 2015.

  • Vortioxetine

    serch.it?q=Vortioxetine

    Vortioxetine, sold under the trade names Trintellix and Brintellix, is an antidepressant medication that is used to treat depression. It increases serotonin concentrations in the brain by inhibiting its reuptake in the synapse, and by modulating (activating certain receptors while blocking, or antagonizing, others) certain serotonin receptors. This puts it in the class of atypical antidepressants known as serotonin modulators and stimulators. It is made by the pharmaceutical companies Lundbeck and Takeda.

Map Box 1